ABSTRACT
Introducción: Los trastornos del comportamiento y del aprendizaje se describen con frecuencia en < 1.500 g o < 32 semanas (RNMBP/MP). Se dispone de muy poca información en población española. Objetivo: Identificar los problemas psicosociales de los RNMBP/MP mediante la aplicación del test Strength and Difficulties Questionnaire (SDQ) a los 6 años y comparar los resultados con los de una población de referencia. Establecer los puntos de corte para el uso del SDQ como cribado del trastorno por déficit de atención e hiperactividad (TDAH) en RNMBP/MP. Participantes y métodos: Estudio prospectivo observacional en RNMBP/MP evaluados a los 6 años con SDQ. Se recogen variables perinatales, neurodesarrollo y diagnóstico de TDAH mediante DSM-5. Resultados: Se incluyeron 214 niños con el total de las valoraciones. Comparados con la población de referencia obtuvieron puntuaciones significativamente mayores en síntomas emocionales, relaciones con compañeros y en el total del test. La escala de hiperactividad y la puntuación total se identifican como buenos predictores del diagnóstico de TDAH, con un área bajo la curva ROC de 0,83 y 0,87, respectivamente. Las puntuaciones que consiguen una adecuada sensibilidad para el cribado de TDAH son ≥ 6 para la escala de hiperactividad y ≥ 13 para la puntuación total del test, y una puntuación combinada ≥ 5 en hiperactividad junto con un total ≥ 12. Conclusiones: Los RNMBP/MP presentan más frecuentemente problemas emocionales y de relación que sus compañeros nacidos a término. El test SDQ podría utilizarse como una prueba de cribado para el TDAH
Introduction: Behavioural disorders and learning disabilities are often recognised in < 1,500g or < 32 weeks very low birth weight (VLBW) infants. There is very limited data in the Spanish population. Objective: To determine the presence of psychosocial disorders in preterm infants at 6 years of age, as assessed by the strength and difficulties (SDQ) questionnaire, in comparison to a reference population. To set a cut-off value to use SDQ as a screening tool for attention deficit hyperactivity disorder (ADHD) in the preterm child. Participants and methods: A prospective observational study was conducted on premature children assessed at 6 years of age using the SDQ. Perinatal variables, neurodevelopment, and diagnosis of ADHD, according to the DSM-5, were collected. Results: A total of 214 children who met all the requirements, were included. When compared with the reference population they had significantly higher scores in emotional symptoms, in peer relationships, and in the total score of the test. The hyperactivity scale and the total test score are good predictors of a diagnosis of ADHD, with an area under the ROC curve of 0.83 (95% CI: 0.76-0.90) for hyperactivity, and 0.87 (95% CI: 0.80-0.93) for the total score. The scores for hyperactivity and the total test, from which the screening for ADHD could be considered positive would be ≥ 6 and ≥ 13 respectively, and a combination of hyperactivity ≥ 5 and total score ≥ 12. Conclusions: Preterm children are at higher risk of emotional and peer relationship problems than those born full term. The SDQ test could be used for ADHD screening
Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Child , Attention Deficit Disorder with Hyperactivity/diagnosis , Mass Screening/methods , Attention Deficit Disorder with Hyperactivity/epidemiology , Infant, Premature , Mental Disorders/diagnosis , Prospective Studies , Surveys and QuestionnairesABSTRACT
INTRODUCTION: Behavioural disorders and learning disabilities are often recognised in<1,500g or<32 weeks very low birth weight (VLBW) infants. There is very limited data in the Spanish population. OBJECTIVE: To determine the presence of psychosocial disorders in preterm infants at 6 years of age, as assessed by the strength and difficulties (SDQ) questionnaire, in comparison to a reference population. To set a cut-off value to use SDQ as a screening tool for attention deficit hyperactivity disorder (ADHD) in the preterm child. PARTICIPANTS AND METHODS: A prospective observational study was conducted on premature children assessed at 6 years of age using the SDQ. Perinatal variables, neurodevelopment, and diagnosis of ADHD, according to the DSM-5, were collected. RESULTS: A total of 214 children who met all the requirements, were included. When compared with the reference population they had significantly higher scores in emotional symptoms, in peer relationships, and in the total score of the test. The hyperactivity scale and the total test score are good predictors of a diagnosis of ADHD, with an area under the ROC curve of 0.83 (95% CI: 0.76-0.90) for hyperactivity, and 0.87 (95% CI: 0.80-0.93) for the total score. The scores for hyperactivity and the total test, from which the screening for ADHD could be considered positive would be≥6 and≥13 respectively, and a combination of hyperactivity≥5 and total score≥12. CONCLUSIONS: Preterm children are at higher risk of emotional and peer relationship problems than those born full term. The SDQ test could be used for ADHD screening.
Subject(s)
Attention Deficit Disorder with Hyperactivity/diagnosis , Mass Screening/methods , Surveys and Questionnaires , Attention Deficit Disorder with Hyperactivity/epidemiology , Child , Child, Preschool , Female , Humans , Infant, Newborn , Infant, Premature , Male , Mental Disorders/diagnosis , Prospective StudiesABSTRACT
BACKGROUND: Early hypophosphatemia is common in premature infants ≤1250 g. The aim of this study was to assess the frequency and severity of hypophosphatemia after sodium glycerophosphate supplementation from first day of life in parenteral nutrition and to address the safety of this practice. METHODS: Prospective cohort study of infants ≤1250 g birth weight born in a tertiary-care level neonatal intensive care unit and supplied with sodium glycerophosphate from the first day of life. Primary outcome was the presence of hypophosphatemia (<4 mg/dL) on the first week. Data were compared with our 2014 prospective subcohort of infants ≤1250 g receiving phosphate after 48 hours of life and morbidity with that of our 2016 retrospective cohort of ≤1250 g. RESULTS: Fifty-four neonates were included. The frequency of hypophosphatemia was 29.6%. Only 1 patient presented hypophosphatemia <2 mg/dL. Mild hypokalemia was found in 8 patients (50%). No cases of hypernatremia were observed. Patients with hypophosphatemia had significantly lower gestational age (27.4 vs 28.8 weeks, P = .032) and lower z-score birth weight (-1.68 vs -0.47; P = .001). When compared with the 2014 subcohort, we found a lower frequency of hypophosphatemia (29.6% vs 69.2%; P = .008) and a lower rate of samples with hypophosphatemia (20.4% vs 51.4%; P = .0002) and critical hypophosphatemia (0.68% vs 11.4%, P = .0005). No differences were found in morbidity or mortality. CONCLUSIONS: Sodium glycerophosphate supplementation in parenteral nutrition from the first day of life significantly decreased the frequency of hypophosphatemia. No adverse events were reported.
